Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionJohn J.V. McMurray, Anna-Maria Langkilde, Mikhail Kosiborod et al.|New England Journal of Medicine|2019Cited by 6.8k
Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesStephen D. Wiviott, Marc S. Sabatine, Itamar Raz et al.|New England Journal of Medicine|2018Cited by 6.3k